{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:41:01Z","timestamp":1770997261792,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T00:00:00Z","timestamp":1305590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10620-011-1745-4","type":"journal-article","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T02:10:07Z","timestamp":1305511807000},"page":"3305-3315","source":"Crossref","is-referenced-by-count":32,"title":["Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis\u00a0C Identified by Serum Proteomics"],"prefix":"10.1007","volume":"56","author":[{"given":"Libang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle D.","family":"Rudser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LeeAnn","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo R.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Corless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn R.","family":"Gourley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"key":"1745_CR1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","volume":"132","author":"TJ Liang","year":"2000","unstructured":"Liang TJ, Reherman B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment and prevention of hepatitis\u00a0C. Ann Intern Med. 2000;132:296\u2013305.","journal-title":"Ann Intern Med"},{"key":"1745_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis\u00a0C. Lancet. 1997;349:825\u2013832.","journal-title":"Lancet"},{"key":"1745_CR3","volume-title":"Clinical Transplants","author":"EC Seaberg","year":"1998","unstructured":"Seaberg EC, Belle SH, Beringer KC, et\u00a0al. Liver transplantation in the United States from 1987\u20131998: updated results from the Pitt-UNOS Liver Transplant Registry. In: Cecka M, Terasaki PI, eds. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratory; 1998."},{"key":"1745_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","volume":"124","author":"MG Ghany","year":"2003","unstructured":"Ghany MG, Kleiner DE, Alter H, et\u00a0al. Progression of fibrosis in chronic hepatitis\u00a0C. Gastroenterology. 2003;124:97\u2013104.","journal-title":"Gastroenterology"},{"key":"1745_CR5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/gut.2006.113217","volume":"56","author":"KR Neal","year":"2007","unstructured":"Neal KR, Ramsay S, Thomson BJ, Irving WL. Excess mortality rates in a cohort of patients infected with the hepatitis\u00a0C virus: a prospective study. Gut. 2007;56:1098\u20131104.","journal-title":"Gut"},{"key":"1745_CR6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838\u2013851.","journal-title":"Lancet"},{"key":"1745_CR7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","volume":"38","author":"T Poynard","year":"2003","unstructured":"Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology. 2003;38:481\u2013492.","journal-title":"Hepatology"},{"key":"1745_CR8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","volume":"48","author":"HH Thein","year":"2008","unstructured":"Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis\u00a0C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48:418\u2013431.","journal-title":"Hepatology"},{"key":"1745_CR9","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.510230607","volume":"23","author":"M Yano","year":"1996","unstructured":"Yano M, Kumada H, Kage M, et\u00a0al. The long-term pathological evolution of chronic hepatitis\u00a0C. Hepatology. 1996;23:1334\u20131340.","journal-title":"Hepatology"},{"key":"1745_CR10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1381\/0960892053723268","volume":"15","author":"DJ Janiec","year":"2005","unstructured":"Janiec DJ, Jacobson ER, Freeth A, Spaulding L, Blaszyk H. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies. Obes Surg. 2005;15:497\u2013501.","journal-title":"Obes Surg"},{"key":"1745_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","volume":"2","author":"F Piccinino","year":"1986","unstructured":"Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68, 276 biopsies. J Hepatol. 1986;2:165\u2013173.","journal-title":"J Hepatol"},{"key":"1745_CR12","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1053\/gast.2002.1232082","volume":"123","author":"Anonymous","year":"2002","unstructured":"Anonymous. National institutes of health consensus development conference statement: management of hepatitis\u00a0C 2002. Gastroenterology. 2002;123:2082\u20132099.","journal-title":"Gastroenterology"},{"key":"1745_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","volume":"47","author":"IN Guha","year":"2008","unstructured":"Guha IN, Parkes J, Roderick P, et\u00a0al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology. 2008;47:455\u2013460.","journal-title":"Hepatology"},{"key":"1745_CR14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","volume":"50","author":"Y Popov","year":"2009","unstructured":"Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009;50:1294\u20131306.","journal-title":"Hepatology"},{"key":"1745_CR15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/pmic.200300552","volume":"3","author":"B Thome-Kromer","year":"2003","unstructured":"Thome-Kromer B, Bonk I, Klatt M, et\u00a0al. Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics. 2003;3:1835\u20131862.","journal-title":"Proteomics"},{"key":"1745_CR16","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1002\/elps.200305645","volume":"24","author":"G Marko-Varga","year":"2003","unstructured":"Marko-Varga G, Berglund M, Malmstrom J, Lindberg H, Fehniger TE. Targeting hepatocytes from liver tissue by laser capture microdissection and proteomics expression profiling. Electrophoresis. 2003;24:3800\u20133805.","journal-title":"Electrophoresis"},{"key":"1745_CR17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/425441a","volume":"425","author":"D Cyranoski","year":"2003","unstructured":"Cyranoski D. China takes centre stage for liver proteome. Nature. 2003;425:441.","journal-title":"Nature"},{"key":"1745_CR18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1074\/mcp.M200066-MCP200","volume":"1","author":"JN Adkins","year":"2002","unstructured":"Adkins JN, Varnum SM, Auberry KJ, et\u00a0al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Molecular & Cellular Proteomics. 2002;1:947\u2013955.","journal-title":"Molecular & Cellular Proteomics"},{"key":"1745_CR19","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1373\/clinchem.2007.089144","volume":"53","author":"B Gangadharan","year":"2007","unstructured":"Gangadharan B, Antrobus R, Dwek RA, Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis\u00a0C patients. Clin Chem. 2007;53:1792\u20131799.","journal-title":"Clin Chem"},{"key":"1745_CR20","volume-title":"Tietz Fundamentals of Clinical Chemistry","author":"CA Burtis","year":"2001","unstructured":"Burtis CA, Ashwood ER. Tietz Fundamentals of Clinical Chemistry. Philadelphia: W.B. Saunders; 2001."},{"key":"1745_CR21","first-page":"14","volume":"18","author":"C Wrotnowski","year":"1998","unstructured":"Wrotnowski C. The future of plasma proteins. Genet Eng News. 1998;18:14.","journal-title":"Genet Eng News"},{"key":"1745_CR22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2003","unstructured":"Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2003;1:845\u2013867.","journal-title":"Mol Cell Proteomics"},{"key":"1745_CR23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00216-005-3126-3","volume":"382","author":"R Marouga","year":"2005","unstructured":"Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem. 2005;382:669\u2013678.","journal-title":"Anal Bioanal Chem"},{"key":"1745_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bfgp\/ell018","volume":"5","author":"K Aggarwal","year":"2006","unstructured":"Aggarwal K, Choe LH, Lee KH. Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic. 2006;5:112\u2013120.","journal-title":"Brief Funct Genomic Proteomic"},{"key":"1745_CR25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","volume":"19","author":"KP Batts","year":"1995","unstructured":"Batts KP, Ludwig J. Chronic Hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19:1409\u20131417.","journal-title":"Am J Surg Pathol"},{"key":"1745_CR26","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/ac00104a020","volume":"67","author":"JR Yates III","year":"1995","unstructured":"Yates JR III, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem. 1995;67:1426\u20131436.","journal-title":"Anal Chem"},{"key":"1745_CR27","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31:3784\u20133788.","journal-title":"Nucleic Acids Res"},{"key":"1745_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/pr015504q","volume":"1","author":"DL Tabb","year":"2002","unstructured":"Tabb DL, McDonald WH, Yates JR III. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res. 2002;1:21\u201326.","journal-title":"J Proteome Res"},{"key":"1745_CR29","volume-title":"Classification and Regression Trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman J, Olshen R, et\u00a0al. Classification and Regression Trees. Belmont, CA: Wadsworth and Brooks; 1984."},{"key":"1745_CR30","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/ac034869m","volume":"76","author":"Y Shen","year":"2004","unstructured":"Shen Y, Jacobs JM, Camp DG, et\u00a0al. Ultra-high-efficiency strong cation exchange LC\/RPLC\/MS\/MS for high dynamic range characterization of the human plasma proteome. Anal Chem. 2004;76:1134\u20131144.","journal-title":"Anal Chem"},{"key":"1745_CR31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","volume":"357","author":"F Imbert-Bismut","year":"2001","unstructured":"Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis\u00a0C virus infection: a prospective study. Lancet. 2001;357:1069\u20131075.","journal-title":"Lancet"},{"key":"1745_CR32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis\u00a0C. The METAVIR Cooperative Study Group. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u2013293.","journal-title":"Hepatology"},{"key":"1745_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","unstructured":"The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis\u00a0C. Hepatology. 1994;20:15\u201320.","journal-title":"Hepatology"},{"key":"1745_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-5926-1-3","volume":"1","author":"P Halfon","year":"2002","unstructured":"Halfon P, Imbert-Bismut F, Messous D, et\u00a0al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Compar Hepatol. 2002;1:3.","journal-title":"Compar Hepatol"},{"key":"1745_CR35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1373\/49.3.450","volume":"49","author":"E Rossi","year":"2003","unstructured":"Rossi E, Adams L, Prins A, et\u00a0al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis\u00a0C patients. Clin Chem. 2003;49:450\u2013454.","journal-title":"Clin Chem"},{"key":"1745_CR36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et\u00a0al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis\u00a0C. Hepatology. 2003;38:518\u2013526.","journal-title":"Hepatology"},{"key":"1745_CR37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/hep.20099","volume":"39","author":"S Le Calvez","year":"2004","unstructured":"Le Calvez S, Thabut D, Messous D, et\u00a0al. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis\u00a0C. Hepatology. 2004;39:862\u2013863.","journal-title":"Hepatology"},{"key":"1745_CR38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/MEG.0b013e3283293769","volume":"21","author":"OA Gressner","year":"2009","unstructured":"Gressner OA, Gao C, Siluschek M, Kim P, Gressner AM. Inverse association between serum concentrations of actin-free vitamin\u00a0D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2009;21:990\u2013995.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1745_CR39","first-page":"797","volume":"38","author":"N Kawai","year":"1984","unstructured":"Kawai N, Matsumoto H. Vitamin-D binding protein levels in liver cirrhosis, chronic hepatitis, and rheumatoid arthritis. Nihon Hoigaku Zasshi. 1984;38:797\u2013803.","journal-title":"Nihon Hoigaku Zasshi"},{"key":"1745_CR40","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1111\/j.1572-0241.1999.01446.x","volume":"94","author":"Z Ben Ari","year":"1999","unstructured":"Ben Ari Z, Osman E, Hutton RA, Burroughs AK. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol. 1999;94:2977\u20132982.","journal-title":"Am J Gastroenterol"},{"key":"1745_CR41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.52.3.404","volume":"52","author":"GV Papatheodoridis","year":"2003","unstructured":"Papatheodoridis GV, Papakonstantinou E, Andrioti E, et\u00a0al. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut. 2003;52:404\u2013409.","journal-title":"Gut"},{"key":"1745_CR42","first-page":"307","volume":"87","author":"L Mouelhi","year":"2009","unstructured":"Mouelhi L, Mekki H, Debbeche R, Salem M, Najjar T. Thrombosis in inflammatory bowel disease: mechanisms and risk factors. Tunis Med. 2009;87:307\u2013310.","journal-title":"Tunis Med"},{"key":"1745_CR43","doi-asserted-by":"crossref","first-page":"RA203","DOI":"10.12659\/MSM.878203","volume":"15","author":"P Chrusciel","year":"2009","unstructured":"Chrusciel P, Goch A, Banach M, Mikhailidis DP, Rysz J, Goch JH. Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit. 2009;15:RA203\u2013RA208.","journal-title":"Med Sci Monit"},{"key":"1745_CR44","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.3748\/wjg.v11.i32.4997","volume":"11","author":"SM Maksan","year":"2005","unstructured":"Maksan SM, Ulger Z, Gebhard MM, Schmidt J. Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: an in vivo analysis. World J Gastroenterol. 2005;11:4997\u20135001.","journal-title":"World J Gastroenterol"},{"key":"1745_CR45","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/gut.2008.150748","volume":"57","author":"V Calvaruso","year":"2008","unstructured":"Calvaruso V, Maimone S, Gatt A, et\u00a0al. Coagulation and fibrosis in chronic liver disease. Gut. 2008;57:1722\u20131727.","journal-title":"Gut"},{"key":"1745_CR46","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/elps.200500779","volume":"27","author":"A Szilagyi","year":"2006","unstructured":"Szilagyi A, Blasko B, Ronai Z, Fust G, Sasvari-Szekely M, Guttman A. Rapid quantification of human complement component C4A and C4B genes by capillary gel electrophoresis. Electrophoresis. 2006;27:1437\u20131443.","journal-title":"Electrophoresis"},{"key":"1745_CR47","doi-asserted-by":"crossref","first-page":"280.e9","DOI":"10.1016\/j.amjmed.2006.06.044","volume":"120","author":"A Zaman","year":"2007","unstructured":"Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis\u00a0C patients. Am J Med. 2007;120:280.e9\u201314.","journal-title":"Am J Med"},{"key":"1745_CR48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2009.09.005","volume":"409","author":"OA Gressner","year":"2009","unstructured":"Gressner OA, Beer N, Jodlowski A, Gressner AM. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest\/Actitest scores for the non-invasive biochemical assessment of liver fibrosis. Clin Chim Acta. 2009;409:90\u201395.","journal-title":"Clin Chim Acta"},{"key":"1745_CR49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.copbio.2003.12.001","volume":"15","author":"G Bergh Van den","year":"2004","unstructured":"Van den Bergh G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol. 2004;15:38\u201343.","journal-title":"Curr Opin Biotechnol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1745-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1745-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1745-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T16:13:10Z","timestamp":1560183190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1745-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1745-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,17]]}}}